Advertisement

Advertisement

Most Read Stories
Axitinib Plus Pembrolizumab in Advanced Sarcomas
Addition of Tucidinostat to Exemestane in Advanced Hormone Receptor–Positive Breast Cancer
FDA Approves Ramucirumab for Hepatocellular Carcinoma
2019 ASCO: Low-Fat Diet May Reduce the Risk of Death From Breast Cancer in Postmenopausal Women
2019 ASCO: Reduced Chemotherapy Dosages in Elderly Patients With Advanced Gastroesophageal Cancer
Tumor Mutational Burden as a Marker of Response to Immunotherapy in MSI-High Metastatic Colorectal Cancer
2019 ASCO: Lenalidomide May Reduce the Risk of Smoldering Multiple Myeloma Progressing to Active Disease
Harnessing the Power of Twitter for Clinical Trial Enrollment and Success
2019 ASCO: Nearly One-Quarter of Participants in the Pediatric MATCH Trial Have an Actionable Molecular Alteration
Neoadjuvant Immunotherapy Associated With Improved Outcomes in Patients With Locally Advanced Melanoma
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Front-Line Therapy in Advanced Renal Cell Carcinoma: Developing a New Standard
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
2019 ASCO: Entrectinib in Children and Adolescents With Recurrent or Refractory Solid or Central Nervous System Tumors
Lifetime Risk of Brain Metastases in Elderly Survivors of Breast, Lung, and Skin Cancers
How I Work up the Patient with Thrombocytosis
HPV DNA and Outcomes After Primary Treatment for Oral and Oropharyngeal Squamous Cell Carcinomas
Study Finds New Candidate Susceptibility Genes for High-Grade Serous Ovarian Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
'Oral Cryotherapy' for Patients Undergoing Oxaliplatin-Based Chemotherapy

Advertisement

Advertisement



;
Advertisement